AU5781900A - 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activityand for use in cancer chemotherapy - Google Patents

3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activityand for use in cancer chemotherapy

Info

Publication number
AU5781900A
AU5781900A AU57819/00A AU5781900A AU5781900A AU 5781900 A AU5781900 A AU 5781900A AU 57819/00 A AU57819/00 A AU 57819/00A AU 5781900 A AU5781900 A AU 5781900A AU 5781900 A AU5781900 A AU 5781900A
Authority
AU
Australia
Prior art keywords
heteroarylidenyl
activityand
protein kinase
cancer chemotherapy
modulating protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57819/00A
Inventor
Peter J. Langecker
Laura K Shawver
Li Sun
Peng C. Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sugen LLC
Original Assignee
Sugen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/476,232 external-priority patent/US20030073837A1/en
Priority claimed from PCT/US1999/031232 external-priority patent/WO2000038519A1/en
Application filed by Sugen LLC filed Critical Sugen LLC
Priority claimed from PCT/US2000/018058 external-priority patent/WO2001049287A1/en
Publication of AU5781900A publication Critical patent/AU5781900A/en
Abandoned legal-status Critical Current

Links

AU57819/00A 1999-12-30 2000-06-30 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activityand for use in cancer chemotherapy Abandoned AU5781900A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
WOUS99/31232 1999-12-30
US09/476,232 US20030073837A1 (en) 1998-12-31 1999-12-30 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
PCT/US1999/031232 WO2000038519A1 (en) 1998-12-31 1999-12-30 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
US09476232 1999-12-30
US56954500A 2000-05-12 2000-05-12
US09569545 2000-05-12
PCT/US2000/018058 WO2001049287A1 (en) 1999-12-30 2000-06-30 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy

Publications (1)

Publication Number Publication Date
AU5781900A true AU5781900A (en) 2001-07-16

Family

ID=27045125

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57819/00A Abandoned AU5781900A (en) 1999-12-30 2000-06-30 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activityand for use in cancer chemotherapy

Country Status (2)

Country Link
AT (1) ATE336245T1 (en)
AU (1) AU5781900A (en)

Also Published As

Publication number Publication date
ATE336245T1 (en) 2006-09-15

Similar Documents

Publication Publication Date Title
EP1139754A4 (en) 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
AU5173400A (en) Protein kinases
AU2437900A (en) Piperidinylquinolines as protein tyrosine kinase inhibitors
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
IL141866A0 (en) Pyrrolopyrimidines as protein kinase inhibitors
AU2001249865A1 (en) Pyrazoles for inhibiting protein kinase
AU2001253140A1 (en) Tumor markers in ovarian cancer
EP1391218A3 (en) Longitudinally aligned dual reservoir access port
AU3546400A (en) Tandem immuno-assay for cancer
AU2001292802A1 (en) Genetic markers for tumors
AU2001247882A1 (en) Tricyclic protein kinase inhibitors
AU3155501A (en) Spreading factor determination
AU2187301A (en) Protein kinase regulation
AU2576501A (en) Protein kinase inhibitors
HUP0103079A3 (en) Modulating multiple lineage kinase proteins
AU1189201A (en) Therapeutic compositions including protein kinase c inhibitors
AU3703499A (en) Substituted indolinones as kinase inhibitors
AU2113899A (en) Human protein kinase molecules
AU5124500A (en) Tumor necrosis factor-gamma
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU5781900A (en) 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activityand for use in cancer chemotherapy
IL154311A0 (en) Modulating multiple lineage kinase proteins
AU1800700A (en) Ikk3 kinase
AU2538899A (en) Protein kinase c
AU5032400A (en) Sigma-1 ligands useful for determining the proliferative status of cancer cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase